XanthaPhage Agricultural solution to combat plant diseases like rice blight, improving crop yields for countries which depend on rice-based diets
Auxergen projects potential revenue as follows :
As a Qualified Maryland Biotechnology Company (QMBC), investors have access to the Maryland Biotechnology Investment Incentive Tax Credit (BIITC). QMBC status enables investors to receive a 33% income tax credit on eligible investments, up to $250,000 per investor.
An investment of $750,000 in Auxergen can yield a $250,000 tax credit from the State of Maryland. This opportunity is open to investors globally, as long as they are from a jurisdiction with a US-correspondent tax system.
The company is aiming to raise $11 million, capital designated to facilitate the commercialization of our XylePhage product. This promising product is positioned as a solution to the Olive Quick Decline Syndrome (OQDS), which is presently undermining European olive oil production on a large scale.